FTC 'Still In The Game' On Pay-For-Delay Challenges

By Melissa Lipman (May 4, 2012, 8:09 PM EDT) -- Despite a recent appellate ruling blessing pay-for-delay settlements that stay within the scope of the contested patent, the head of the Federal Trade Commission's health care unit warned Friday that the agency would not be dissuaded from challenging the deals between generic- and brand-drug makers....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!